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Abstract
Background: The majority of Marfan syndrome (MFS) cases is caused by mutations in the fibrillin-1 gene (FBN1),
mapped to chromosome 15q21.1. Only few reports on deletions including the whole FBN1 gene, detected by
molecular cytogenetic techniques, were found in literature.
Results: We report here on a female patient with clinical symptoms of the MFS spectrum plus craniostenosis,
hypothyroidism and intellectual deficiency who presents a 1.9 Mb deletion, including the FBN1 gene and a
complex rearrangement with eight breakpoints involving chromosomes 6, 12 and 15.
Discussion: This is the first report of MFS with a complex chromosome rearrangement involving a deletion of
FBN1 and contiguous genes. In addition to the typical clinical findings of the Marfan syndrome due to FBN1 gene
haploinsufficiency, the patient presents features which may be due to the other gene deletions and possibly to the
complex chromosome rearrangement.
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Background
Marfan syndrome (MFS) is a dominant disorder, mainly
caused by mutations in the fibrillin-1 gene (FBN1)
located on chromosome 15q21.1. The estimated preva-
lence of MFS is about 1 in 10000. Approximately 25%
of MFS patients are sporadic cases due to new muta-
tions [1,2]. Different tissues and organs can be affected,
especially the cardiovascular, skeletal, and ocular sys-
tems. Diagnostic criteria are well established and known
as the Ghent criteria [3]. However, the inter- and intra-
familial variability of the phenotype limits the establish-
ment of genotype-phenotype correlations. To date, more
than 1329 FBN1 mutations have been published (http://
www.hgmd.cf.ac.uk/ac/gene.php?gene=FBN1), but only a
few are recurring mutations. Missense mutations substi-
tuting or creating a cysteine molecule in one of the cal-
cium-binding EGF domains are the most prevalent. The
others are frameshift, splice-site, nonsense mutations
and in-frame deletions and insertions. Heterozygous
mutations in the genes coding for transforming growth
factor beta receptors I (TGFBR1) and II (TGFBR2) have
also been reported in patients with MFS and MFS-
related disorders, indicating genetic heterogeneity [4-6].
Interstitial deletions involving the 15q21.1 band and the
FBN1 gene are very rare. To our best knowledge, there
are only six reports in the literature describing deletions
of the whole FBN1 gene detected by molecular techni-
ques, and only in five of them this gene deletion was
associated with classical MFS [2,7-11]. The patients
described by Adès et al. [8] and Hutchinson et al. [7]
had clinical features of the MFS spectrum and mental
retardation, but the size of their deletions was not deter-
mined. The patient described by Faivre et al. [10] had a
2.97 Mb deletion and some features of MFS but no
mental retardation. Hilhorst-Hofstee et al. [2] described
10 cases (five of the same family) with a complete FBN1
gene deletion, screened by Multiplex Ligation-dependent
Probe Amplification (MLPA) analysis of 300 patients
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presenting from mild MFS features to the classical MFS
or an MFS-related phenotype. Recently, Furtado et al.
[11] studied 14 patients from 11 unrelated families with
aortic aneurysm. Three patients of the one family who
met clinical diagnostic criteria for Marfan syndrome had
a 542 Kb deletion in chromosome 15 including the
whole FBN1 gene; the study of the region was refined
by MLPA and array analysis. Cases with chromosomal
alterations including a genomic deletion of the whole
FBN1 gene are rare, but their number has increased
after the adoption of routine screening by molecular
techniques (MLPA, array), especially in patients with
MFS. To date, there is no description in the literature of
a patient with MFS and a complex chromosome rear-
rangement (CCR). We report here on a 16-year-old
female patient displaying features of the MFS spectrum
and mental retardation, who was found to present a 1.9
Mb deletion at 15q21.1 (refined by array) including the
FBN1 gene, and a novel CCR among chromosomes 6,
12 and 15.
Case presentation
The proband (Figure 1) is the first child of healthy par-
ents. She was born at term, with a length of 50 cm and
a weight of 3240 g. She walked at 18 months, and spoke
at four years of age. She was however able to attend a
regular school, but showed hyperactivity and difficulty
to focus. She had a seizure at the age of 3 years, and a
cardiac examination evidenced mitral insufficiency with
a dystrophic valve. An evolutive scoliosis was noted at
the age of 6 years, with progression. At age 11,
hypothyroidism was detected. She was referred at 13
years of age for a suspicion of MFS, showing: positive
thumb and wrist sign, scoliosis, joint hyperlaxity, high-
arched palate with dental crowding, dysmorphism and
aortic root dilatation with dystrophic mitral valve.
Ophthalmological examination revealed myopia and
astigmatism but not ectopia lentis. A neuropsychological
assessment showed global intellectual impairment (IQ
50) according to the Brazilian values of the Wechsler
Intelligence Scale for Children-III (WISC-III), with
major deficits in attention and executive skills. Thus,
she met the Ghent criteria for Marfan syndrome, but
also presented craniostenosis, hypothyroidism and intel-
lectual deficiency.
Genetic Study
Classical Cytogenetic Findings
Conventional chromosome analysis was performed on
phytohemagglutinin-stimulated lymphocytes from per-
ipheral blood cultures, using GTG banding according to
standard protocols. Cell images were captured using the
Ikaros Digital Imaging System (Metasystem, Altlussheim,
Germany). G-banded analysis with a resolution of 550
bands per haploid karyotype revealed a female karyotype
with a de novo balanced translocation involving chromo-
somes 6, 12 and 15, with breakpoints apparently at
6q22, 12q24 and 15q21 (Figure 2A).
Molecular Findings
Genomic DNA was isolated from peripheral blood using
a Gentra Puregene kit (Qiagen Sciences, Inc., German-
town, MD). Array study was performed with Affymetrix
Cytogenetics Array 2.7 (Affymetrix Inc., Santa Clara,
CA, USA) according to the manufacturer’s instructions,
using the Affymetrix Chromosome Analysis Suite soft-
ware. Copy number state indicated an apparently contig-
uous interstitial deletion (~1.9 Mb) on chromosome
15q21.1 in the region 45,466,733-47,335,104 bp
(NCBI36/hg18) (Figure 2B). Parental array analysis
showed normal results.
Molecular Cytogenetic Findings
In order to better characterize the complex chromo-
some rearrangement, FISH was performed with region-
specific BAC probes for chromosomes 6q, 12q and
15q. Clones were selected from the BACPAC Resource
Center at the Children’s Hospital Oakland Research
Institute (Oakland, CA, USA) and prepared according
to Guilherme et al. [12]. FISH was performed with
whole chromosome painting (WCP) probes for chro-
mosomes 6, 12 and 15 (Cytocell, Cambrigde, UK).
Individual and combined WCP probes were used in
order to clarify the complex chromosomal rearrange-
ment. Cell images were captured using the Isis Digital
Imaging System (Metasystem, Altlussheim, Germany).
Figure 1 Patient at age 13 years.
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FISH analysis revealed a quite complex rearrangement
with eight breakpoints, as follows:
46, XX, t(6;12;15)
(6pter®6q14::15q15.1®15q21.1::15q21.1®15q22.3::6-
q14®6q21::12q24.1®12qter;12p-
ter®12q24.1::6q21®6q22.2::15q22.3®15qter;15p-
ter®15q15.1::6q22.2®6qter)dn.arr 15q21.1(45,466,733-
47,335,104)×1 (Figure 2C, D and 2E).
Discussion
We report here on a girl with clinical features of the
MFS spectrum and a 15q21.1 deletion including the
entire FBN1 gene. This is the seventh study in the litera-
ture in which the deletion of FBN1 is confirmed by
molecular techniques. Thus, to this date 18 patients
with deletions including the whole FBN1 gene were
reported, five of them belonging to the same family.
Figure 2 Cytogenetic and molecular data from the patient studied. A) GTG-banded chromosomes showing the translocation involving
chromosomes 6, 12 and 15. B) Array result for chromosome 15 showing the 1.9 Mb deletion (red) at 15q21.1 including the FBN1 gene (arrow).
C) FISH with WCP probes of chromosomes 6, 12 and 15 in different color combinations showing a complex chromosomal rearrangement. D)
FISH with probes RP11-631P6 (6q13) in red and RP11-46N22 (6q14.3) in green, showing signals next to each other on the normal chromosome 6
and separate signals on the der (6) chromosome. E) FISH with probes RPRP11-627A9 (15q23) in green and RP11-793M16 (12q24.13) in red,
showing signals of both on the derivative chromosome 12. F) Ideogram of the derivative chromosomes involved in the patient’s complex
chromosome rearrangement, showing the probes used to define the breakpoints and the 15q21.1 band deletion (arrow).
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Interestingly, only 12 of these patients [2,7,11, present
case] present the typical MFS phenotype according to
the Ghent criteria. Clinical variability in patients with
different point mutations has been described, with
patients with a nonsense mutation presenting milder
phenotypes than patients with a missense mutation [10].
Cases with a deletion can be compared to patients with
a nonsense mutation, since the truncated mRNA in the
latter cases is believed to be reduced, due to the non-
sense-mediated decay (NMD) mechanism that prevents
the expression of the truncated mRNA [2,10,13]. Thus,
in cases of deletion and nonsense mutation, the MFS
phenotype can result from FBN1 gene haploinsufficiency
and, especially in cases of missense mutations, from a
dominant negative effect. Hutchinson et al [7] suggested
that the clinical variability in MFS could be also due to
variable FBN1 expression of the normal allele. The size
of the deletions reported varies from small (less than
300 kb in 5 members of the same family) [2], including
only the FBN1 gene, to large (up to 17.7 Mb) [9]. As
found in our patient, when the deletion involves other
genes besides FBN1, other unusual features can be
found, such as those described here (craniostenosis,
hypothyroidism and intellectual deficit). The patient
described by Hiraki et al [9] presented no sign of the
MFS syndrome, probably due to her young age and
severe clinical phenotype. Our patient showed most of
the skeletal features of MFS and an aortic root dilata-
tion, but no ectopia lentis. Concerning the ocular sys-
tem, she presented myopia and astigmatism. Her
deletion comprises 19 genes and predicted genes includ-
ing FBN1, besides SEMA6D and COPS2 that may have
contributed to the intellectual deficit and hypothyroid-
ism, respectively. Of the 18 patients with a complete
deletion of the FBN1 gene described so far, only seven
were karyotyped: two presented normal karyotypes
[2,10], three had visible 15q deletions [7-9], and one had
a de novo translocation between the long arms of chro-
mosomes 12 and 15 and a 4.9 Mb interstitial deletion at
the translocation breakpoint of the long arm of chromo-
some 15 between the bands q21.1 and q21.2 [2]. Hil-
horst-Hofstee et al [2] performed karyotype analysis
only in two patients, as part of the mental retardation
screening. So, our patient is the first MFS case described
presenting a complex chromosome rearrangement
among chromosomes 6, 12 and 15. In the literature, up
to 30-50% of the patients with a chromosomal rearran-
gement, both complex and reciprocal translocations,
show an imbalance on the chromosomal or molecular
level as an explanation for their phenotype [14]. The
greater the number of breakpoints involved in a CCR,
the greater the likelihood of genomic imbalances or
position effect. Disruption of a gene could unmask a
recessive mutation on the homologue allele, suggesting
a greater chance for an abnormal phenotypic outcome
[15].
Conclusion
We emphasize the importance of using a combination
of different molecular cytogenetic techniques in cases of
chromosomal and/or genomic rearrangements involving
the FBN1 gene, in order to better understand the extent
of the molecular etiology of the Marfan syndrome and
also to elucidate the genetic constitution of CCRs asso-
ciated with diseases.
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